Short-term outcome of endovascular stenting for symptomatic vertebrobasilar stenosis

Abstract Background Stroke is a global health concern, causing blood supply interruption to the brain. Vertebrobasilar stenosis (VBS) is the main concern, causing stroke or ischemic attacks. Treatment includes antithrombotic therapy and lifestyle modifications, but invasive intervention like endovas...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed Abdel moneim Abdo Tolba, Mohammed Alaswad, Mohamed Mohamed Tawfik, Ahmed Zaki Akl, Mona Ali Eissa, Hala El-khawas, Hani Mahmoud Zaki Eldin, Mohamed Khaled Ahmed Elewa
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Online Access:https://doi.org/10.1186/s41983-025-00937-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571965723901952
author Mohamed Abdel moneim Abdo Tolba
Mohammed Alaswad
Mohamed Mohamed Tawfik
Ahmed Zaki Akl
Mona Ali Eissa
Hala El-khawas
Hani Mahmoud Zaki Eldin
Mohamed Khaled Ahmed Elewa
author_facet Mohamed Abdel moneim Abdo Tolba
Mohammed Alaswad
Mohamed Mohamed Tawfik
Ahmed Zaki Akl
Mona Ali Eissa
Hala El-khawas
Hani Mahmoud Zaki Eldin
Mohamed Khaled Ahmed Elewa
author_sort Mohamed Abdel moneim Abdo Tolba
collection DOAJ
description Abstract Background Stroke is a global health concern, causing blood supply interruption to the brain. Vertebrobasilar stenosis (VBS) is the main concern, causing stroke or ischemic attacks. Treatment includes antithrombotic therapy and lifestyle modifications, but invasive intervention like endovascular angioplasty is needed in indicated patients. This study aims to investigate the short-term outcome of endovascular stenting, especially, drug-eluting stents (DES) for symptomatic vertebrobasilar stenosis. In this prospective cohort study, we selected patients with ischemic events, including transient ischemic attack (TIA) or non-disabling stroke, diagnosed by CT or MRI brain, MRA, and over 70% diameter stenosis of the basilar or vertebral artery suggested by angiography. Patients with previous stent at the target lesion, acute stroke, heavily calcified lesion, complete artery occlusion, massive infarction with marked neurological deficit, intracranial hemorrhage, intracranial brain tumors, contraindicated to antithrombotic and/or anticoagulant, pregnant women, and patients susceptible to follow-up loss were excluded. Results This study involved 17 patients evaluated for ischemic events in the vertebrobasilar system, with a mean age of 58.47 ± 9.41 years. The most prevalent comorbidity was a previous transient ischemic attack (TIA) in 15 patients (88.2%), followed by hypertension in 12 patients (70.6%), diabetes and hyperlipidemia in 10 patients each (58.8% for both). Ischemic heart disease was present in 6 patients (35.3%), and smoking was reported by 5 patients (29.4%). The predominant stenosis location was intracranial in 11 patients (64.7%), with extracranial being the second most prevalent site in 6 patients (35.3%). The most prevalent kind of stenosis observed was atherosclerosis, affecting 11 patients (64.7%), followed by dissection in 6 patients (35.2%). The peri-procedural outcomes were good in 15 patients (88.2%) and bad in 2 patients (11.8%). The modified Rankin score (MRS) score was significantly decreased after 5-month follow-up than pre-operative. There was no statistically significant difference between extracranial and intracranial stenosis regarding the final outcome, residual stenosis, or peri-procedural complications. Conclusions Our findings emphasize the potential advantages of stenting for carefully chosen individuals with symptomatic vertebrobasilar stenosis and simple lesion morphologies (Mori types A and B). However, further research is needed for patient selection and therapy optimization.
format Article
id doaj-art-e5b476bbe2974a92bf073fa5db7626dc
institution Kabale University
issn 1687-8329
language English
publishDate 2025-01-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
spelling doaj-art-e5b476bbe2974a92bf073fa5db7626dc2025-02-02T12:13:27ZengSpringerOpenThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery1687-83292025-01-016111910.1186/s41983-025-00937-wShort-term outcome of endovascular stenting for symptomatic vertebrobasilar stenosisMohamed Abdel moneim Abdo Tolba0Mohammed Alaswad1Mohamed Mohamed Tawfik2Ahmed Zaki Akl3Mona Ali Eissa4Hala El-khawas5Hani Mahmoud Zaki Eldin6Mohamed Khaled Ahmed Elewa7Ain Shams UniversitySuez Canal UniversityAin Shams UniversityAin Shams UniversityHelwan UniversityAin Shams UniversityAin Shams UniversityAin Shams UniversityAbstract Background Stroke is a global health concern, causing blood supply interruption to the brain. Vertebrobasilar stenosis (VBS) is the main concern, causing stroke or ischemic attacks. Treatment includes antithrombotic therapy and lifestyle modifications, but invasive intervention like endovascular angioplasty is needed in indicated patients. This study aims to investigate the short-term outcome of endovascular stenting, especially, drug-eluting stents (DES) for symptomatic vertebrobasilar stenosis. In this prospective cohort study, we selected patients with ischemic events, including transient ischemic attack (TIA) or non-disabling stroke, diagnosed by CT or MRI brain, MRA, and over 70% diameter stenosis of the basilar or vertebral artery suggested by angiography. Patients with previous stent at the target lesion, acute stroke, heavily calcified lesion, complete artery occlusion, massive infarction with marked neurological deficit, intracranial hemorrhage, intracranial brain tumors, contraindicated to antithrombotic and/or anticoagulant, pregnant women, and patients susceptible to follow-up loss were excluded. Results This study involved 17 patients evaluated for ischemic events in the vertebrobasilar system, with a mean age of 58.47 ± 9.41 years. The most prevalent comorbidity was a previous transient ischemic attack (TIA) in 15 patients (88.2%), followed by hypertension in 12 patients (70.6%), diabetes and hyperlipidemia in 10 patients each (58.8% for both). Ischemic heart disease was present in 6 patients (35.3%), and smoking was reported by 5 patients (29.4%). The predominant stenosis location was intracranial in 11 patients (64.7%), with extracranial being the second most prevalent site in 6 patients (35.3%). The most prevalent kind of stenosis observed was atherosclerosis, affecting 11 patients (64.7%), followed by dissection in 6 patients (35.2%). The peri-procedural outcomes were good in 15 patients (88.2%) and bad in 2 patients (11.8%). The modified Rankin score (MRS) score was significantly decreased after 5-month follow-up than pre-operative. There was no statistically significant difference between extracranial and intracranial stenosis regarding the final outcome, residual stenosis, or peri-procedural complications. Conclusions Our findings emphasize the potential advantages of stenting for carefully chosen individuals with symptomatic vertebrobasilar stenosis and simple lesion morphologies (Mori types A and B). However, further research is needed for patient selection and therapy optimization.https://doi.org/10.1186/s41983-025-00937-wDrug eluting stentVertebrobasilar stenosisEndovascular
spellingShingle Mohamed Abdel moneim Abdo Tolba
Mohammed Alaswad
Mohamed Mohamed Tawfik
Ahmed Zaki Akl
Mona Ali Eissa
Hala El-khawas
Hani Mahmoud Zaki Eldin
Mohamed Khaled Ahmed Elewa
Short-term outcome of endovascular stenting for symptomatic vertebrobasilar stenosis
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Drug eluting stent
Vertebrobasilar stenosis
Endovascular
title Short-term outcome of endovascular stenting for symptomatic vertebrobasilar stenosis
title_full Short-term outcome of endovascular stenting for symptomatic vertebrobasilar stenosis
title_fullStr Short-term outcome of endovascular stenting for symptomatic vertebrobasilar stenosis
title_full_unstemmed Short-term outcome of endovascular stenting for symptomatic vertebrobasilar stenosis
title_short Short-term outcome of endovascular stenting for symptomatic vertebrobasilar stenosis
title_sort short term outcome of endovascular stenting for symptomatic vertebrobasilar stenosis
topic Drug eluting stent
Vertebrobasilar stenosis
Endovascular
url https://doi.org/10.1186/s41983-025-00937-w
work_keys_str_mv AT mohamedabdelmoneimabdotolba shorttermoutcomeofendovascularstentingforsymptomaticvertebrobasilarstenosis
AT mohammedalaswad shorttermoutcomeofendovascularstentingforsymptomaticvertebrobasilarstenosis
AT mohamedmohamedtawfik shorttermoutcomeofendovascularstentingforsymptomaticvertebrobasilarstenosis
AT ahmedzakiakl shorttermoutcomeofendovascularstentingforsymptomaticvertebrobasilarstenosis
AT monaalieissa shorttermoutcomeofendovascularstentingforsymptomaticvertebrobasilarstenosis
AT halaelkhawas shorttermoutcomeofendovascularstentingforsymptomaticvertebrobasilarstenosis
AT hanimahmoudzakieldin shorttermoutcomeofendovascularstentingforsymptomaticvertebrobasilarstenosis
AT mohamedkhaledahmedelewa shorttermoutcomeofendovascularstentingforsymptomaticvertebrobasilarstenosis